The Changing Face of Clinical Trials in Psoriatic Arthritis

被引:0
|
作者
Alexis Ogdie
Laura Coates
机构
[1] University of Pennsylvania,Division of Rheumatology, Departments of Medicine and Biostatistics and Epidemiology, Center for Clinical Epidemiology and Biostatistics, Perelman School of Medicine
[2] University of Leeds,Leeds Institute of Rheumatic and Musculoskeletal Medicine
[3] Chapel Allerton Hospital,undefined
来源
关键词
Psoriatic arthritis; Clinical trials; Treatment;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 50 条
  • [21] Ethical and practical issues in conducting clinical trials in psoriasis and psoriatic arthritis
    Kavanaugh, A
    ANNALS OF THE RHEUMATIC DISEASES, 2005, 64 : 46 - 48
  • [22] International Patient and Physician Consensus on Psoriatic Arthritis Outcomes for Clinical Trials
    Orbai, Ana-Maria
    de Wit, Maarten
    Mease, Philip J.
    Shea, Judy A.
    Gossec, Laure
    Leung, Ying Ying
    Tillett, William
    Elmamoun, Musaab
    Duffin, Kristina Callis
    Campbell, Willemina
    Christensen, Robin
    Coates, Laura C.
    Dures, Emma
    Eder, Lihi
    FitzGerald, Oliver
    Gladman, Dafna D.
    Goel, Niti
    Grieb, Suzanne
    Hewlett, Sarah
    Hoejgaard, Pil
    Kalyoncu, Umut
    Lindsay, Christine
    McHugh, Neil J.
    Shea, Bev
    Steinkoenig, Ingrid
    Strand, Vibeke
    Ogdie, Alexis
    ARTHRITIS & RHEUMATOLOGY, 2016, 68
  • [23] Measuring psoriatic arthritis symptoms: A core domain in psoriasis clinical trials
    Perez-Chada, Lourdes Maria
    Gottlieb, Alice Bendix
    Cohen, Jeffrey
    Mease, Philip
    Duffin, Kristina Callis
    Garg, Amit
    Latella, John
    Armstrong, April Wang
    Ogdie, Alexis
    Merola, Joseph Frank
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2020, 82 (01) : 54 - 61
  • [24] Systematic review of the use of CRP in clinical trials for psoriatic arthritis: a concern for clinical practice?
    Houttekiet, Charlotte
    de Vlam, Kurt
    Neerinckx, Barbara
    Lories, Rik
    RMD OPEN, 2022, 8 (01):
  • [25] Novel methods of measuring clinical outcomes from psoriasis and psoriatic arthritis clinical trials
    Villacorta, Reginald
    Hay, Joel W.
    Messali, Andrew
    EXPERT REVIEW OF PHARMACOECONOMICS & OUTCOMES RESEARCH, 2014, 14 (04) : 545 - 558
  • [26] A pre-Delphi consensus exercise to define screening for psoriatic arthritis and measurement of psoriatic arthritis symptoms in psoriasis clinical trials
    Perez-Chada, L. M.
    Cohen, J.
    Gottlieb, A.
    Duffin, K. Callis
    Garg, A.
    Latella, J.
    Armstrong, A. W.
    Ogdie, A.
    Merola, J. F.
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2018, 138 (05) : S88 - S88
  • [27] SAFETY OF IXEKIZUMAB IN PATIENTS WITH PSORIATIC ARTHRITIS: AN INTEGRATED ANALYSIS OF 4 CLINICAL TRIALS
    Sesin, C.
    Gallo, G.
    Gellett, A.
    Kronbergs, A.
    Sprabery, A. T.
    Xu, W.
    Patel, H.
    Deodhar, A.
    Combe, B.
    Burmester, G. R.
    ANNALS OF THE RHEUMATIC DISEASES, 2021, 80 : 789 - 789
  • [28] JAK inhibitors, psoriatic arthritis, and axial spondyloarthritis: a critical review of clinical trials
    Keeling, Stephanie
    Maksymowych, Walter P.
    EXPERT REVIEW OF CLINICAL IMMUNOLOGY, 2021, 17 (07) : 701 - 715
  • [29] Clinical features of psoriatic arthritis
    Krueger, GG
    AMERICAN JOURNAL OF MANAGED CARE, 2002, 8 (06): : S160 - S170
  • [30] CLINICAL ASSESSMENT IN PSORIATIC ARTHRITIS
    Salvarani, C.
    Pipitone, N.
    Catanoso, M. G.
    REUMATISMO, 2007, 59 : 68 - 72